BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1849276)

  • 1. Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells.
    Aperia A; Fryckstedt J; Svensson L; Hemmings HC; Nairn AC; Greengard P
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2798-801. PubMed ID: 1849276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.
    Meister B; Fryckstedt J; Schalling M; Cortés R; Hökfelt T; Aperia A; Hemmings HC; Nairn AC; Ehrlich M; Greengard P
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8068-72. PubMed ID: 2573060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na+,K(+)-ATPase phosphorylation in the choroid plexus: synergistic regulation by serotonin/protein kinase C and isoproterenol/cAMP-PK/PP-1 pathways.
    Fisone G; Snyder GL; Aperia A; Greengard P
    Mol Med; 1998 Apr; 4(4):258-65. PubMed ID: 9606178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of electrolyte transport in the kidney through a dopamine- and cAMP-regulated phosphoprotein, DARPP-32.
    Fryckstedt J; Meister B; Aperia A
    J Auton Pharmacol; 1992 Jun; 12(3):183-9. PubMed ID: 1321155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity.
    Hemmings HC; Nairn AC; Elliott JI; Greengard P
    J Biol Chem; 1990 Nov; 265(33):20369-76. PubMed ID: 2173704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and protein phosphatase activity in renal proximal tubules.
    Slobodyansky E; Aoki Y; Gaznabi AK; Aviles DH; Fildes RD; Jose PA
    Am J Physiol; 1995 Feb; 268(2 Pt 2):F279-84. PubMed ID: 7864167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of L-amino acid decarboxylase and DARPP-32 in the kidney.
    Aperia A; Hökfelt T; Meister B; Bertorello A; Fryckstedt J; Holtbäck U; Seri I
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):11S-13S. PubMed ID: 2166532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Na+-K+-ATPase phosphorylation by PKC in the medullary thick ascending limb of Henle in the rat.
    Bertuccio CA; Cheng SX; Arrizurieta EE; Martín RS; Ibarra FR
    Pflugers Arch; 2003 Oct; 447(1):87-96. PubMed ID: 12905033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat hypothalamic extract inhibits vasopressin-stimulated Na+-K+-ATPase activity in the rat renal medulla.
    Pippard C; Baylis PH
    Cell Biochem Funct; 1986 Jan; 4(1):25-9. PubMed ID: 3002655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of protein phosphatase-1 inhibitors, inhibitor-1 and DARPP-32, in renal medulla.
    Higuchi E; Nishi A; Higashi H; Ito Y; Kato H
    Eur J Pharmacol; 2000 Nov; 408(2):107-16. PubMed ID: 11080516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cAMP on the activity and the phosphorylation of Na+,K(+)-ATPase in rat thick ascending limb of Henle.
    Kiroytcheva M; Cheval L; Carranza ML; Martin PY; Favre H; Doucet A; Féraille E
    Kidney Int; 1999 May; 55(5):1819-31. PubMed ID: 10231444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.
    Girault JA; Hemmings HC; Williams KR; Nairn AC; Greengard P
    J Biol Chem; 1989 Dec; 264(36):21748-59. PubMed ID: 2557337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms involved in catecholamine regulation of sodium transport.
    Meister B; Aperia A
    Semin Nephrol; 1993 Jan; 13(1):41-9. PubMed ID: 8381980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-dependent regulation of sodium, potassium-adenosine-tri-phosphatase (Na+, K(+)-ATPase) activity in medullary thick ascending limb of Henle segments. Effect of cyclic-adenosine-monophosphate guanosine-nucleotide-binding-protein activity and arginine vasopressin.
    Fryckstedt J; Aperia A
    Acta Physiol Scand; 1992 Feb; 144(2):185-90. PubMed ID: 1315476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of okadaic acid, calyculin A, and PDBu on state of phosphorylation of rat renal Na+-K+-ATPase.
    Li D; Cheng SX; Fisone G; Caplan MJ; Ohtomo Y; Aperia A
    Am J Physiol; 1998 Dec; 275(6):F863-9. PubMed ID: 9843902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of inhibition of vasopressin-stimulated NA+K+ATPase by atrial natriuretic factor in the rat renal medullary thick ascending limb of Henle's loop.
    Charlton JA; Baylis PH
    Cell Biochem Funct; 1990 Jan; 8(1):25-9. PubMed ID: 2160336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dopamine on adenylate cyclase and Na+,K(+)-ATPase activity in the developing rat renal cortical and medullary tubule cells.
    Fryckstedt J; Svensson LB; Lindén M; Aperia A
    Pediatr Res; 1993 Sep; 34(3):308-11. PubMed ID: 7907783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Na+-K+-ATPase activities in renal tubule segments of rat inner medulla.
    Terada Y; Knepper MA
    Am J Physiol; 1989 Feb; 256(2 Pt 2):F218-23. PubMed ID: 2537021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of protein phosphatase 1 by DARPP-32: studies with recombinant DARPP-32 and synthetic peptides.
    Desdouits F; Cheetham JJ; Huang HB; Kwon YG; da Cruz e Silva EF; Denefle P; Ehrlich ME; Nairn AC; Greengard P; Girault JA
    Biochem Biophys Res Commun; 1995 Jan; 206(2):652-8. PubMed ID: 7826384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.
    Hemmings HC; Greengard P; Tung HY; Cohen P
    Nature; 1984 Aug 9-15; 310(5977):503-5. PubMed ID: 6087160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.